歐化(01711.HK)年度純利跌75.38%至414.2萬港元 末期息0.5港仙
格隆匯6月28日丨歐化(01711.HK)公佈,截至2022年3月31日止年度,公司收入為2.25億港元,同比減少3.86%;毛利為1.43億港元,同比減少6.71%;母公司擁有人應占年內溢利為414.2萬港元,同比減少75.38%;每股基本盈利0.52港仙,擬派末期息每股0.50港仙。
期內,零售分部收入為2.12億港元,佔集團總收入94.1%。"歐化家俬"及"歐化家俬尊尚店"的合共銷售額為1.36億港元,仍為主要收入來源,佔總零售收入64.3%。"at•home"的銷售額增加9.1%至4420萬港元,佔總零售收入20.8%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.